Olanzapine controlled-release - Delpor

Drug Profile

Olanzapine controlled-release - Delpor

Alternative Names: DLP-119

Latest Information Update: 18 May 2017

$50 / €47 *
* $ price applies to USA, Canada and Latin America. € price applies to the rest of the world. Final gross prices may vary according to local VAT.

At a glance

  • Originator Delpor
  • Class Antipsychotics; Benzodiazepines; Oxazepines; Small molecules; Thiazepines
  • Mechanism of Action Dopamine D1 receptor antagonists; Dopamine D2 receptor antagonists; Serotonin 2 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes - Psychotic disorders

Highest Development Phases

  • Research Psychotic disorders

Most Recent Events

  • 18 May 2017 Olanzapine controlled-release - Delpor is available for licensing as of 09 Mar 2017. https://delpor.com/?page_id=323
  • 17 May 2017 Chemical structure information added
  • 24 Feb 2017 Early research in Psychotic disorders in USA (SC)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top